Acellular Dermal Matrices Market

Acellular dermal matrix (ADM) is a biologically derived product, which is devoid of cells.

SEATTLE, WASHINGTON, UNITED STATES, January 10, 2022 /EINPresswire.com/ -- Market Overview:

Acellular dermal matrix is a new type of collagen implant that has a low complication rate. It is currently used for breast reconstruction after amputation due to breast cancer. The FDA has recently issued a warning about this new material. The agency has recommended against using it in patients with acellular dermal matrix contracture. The safety and efficacy of this material are still questionable, but there are promising early results. The tissue used for the graft will be an acellular dermal matrix, which is a biodegradable extracellular matrix mesh derived from bovine, porcine, and human tissues. The acellular dermal matrix may be replaced with the patient's soft tissues. However, the process does not require the patient to undergo a second surgery. Instead, it is an outpatient procedure. There are no known risks associated with the procedure.

𝐆𝐞𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-sample/4362

Competitive Landscape:

Major players operating in the US acellular dermal matrices market include HANS BIOMED CORP., C. R. Bard, Inc., Cook Medical Incorporated, Gunze Corp., Synthes, Inc., Medtronic, Inc., Hospital Innovations, Aziyo Biologics, Integra LifeSciences Corporation, Conmed, Staumann, Allergan, Inc., Stryker Corporation, and Zimmer Biomet.

Key Market Drivers:

Increasing product launches by key market players are expected to augment the growth of the U.S. acellular dermal matrices market. For instance, in August 2021, AlloSource introduced AlloMend^® Ultra-Thick Acellular Dermal Matrix (ADM). The FDA has not cleared the use of acellular dermal matrix in breast surgery. Animal collagen-derived surgical mesh and human collagen-derived surgical mesh have never been approved by the agency. Therefore, the FDA has decided to require a PMA evaluation before a company can market an ADM in breast surgery. ADM has been approved for other uses, such as in orthopedics. The FDA is also considering using it in cosmetic procedures. New regulations related to the usage of acellular dermal matrices are estimated to propel the growth of the U.S. acellular dermal matrices market.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐏𝐃𝐅 𝐁𝐫𝐨𝐜𝐡𝐮𝐫𝐞 𝐰𝐢𝐭𝐡 𝐋𝐚𝐭𝐞𝐬𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 @ https://www.coherentmarketinsights.com/insight/request-pdf/4362

Covid-19 Impact Analysis:

During the COVID-19 pandemic, the increasing focus on the COID positive cases affected the advancements in other medical operations. Moreover, increasing lockdown measures along with transport restrictions also affected the market growth.

Key Takeaways:

The increasing prevalence of key market players in the U.S. region is expected to boost the growth of the U.S. acellular dermal matrices market. For instance, in December 2021, Aziyo Biologics announced the closing of around US$ 14.0 million of a private placement.

Increasing product launches by key market players in the U.S. region is estimated to enhance the growth of the U.S. acellular dermal matrices market. For instance, in September 2018, MTF Biologics launched FlexHD Pliable PRE™ for pre-pectoral breast surgery.

𝗠𝗮𝗷𝗼𝗿 𝗣𝗹𝗮𝘆𝗲𝗿𝘀 𝗔𝗿𝗲: Zimmer Biomet, Stryker Corporation, Staumann, Allergan, Inc., Conmed, Integra LifeSciences Corporation, Aziyo Biologics, Hospital Innovations, Medtronic, Inc., Synthes, Inc., Gunze Corp., Cook Medical Incorporated, C. R. Bard, Inc., and HANS BIOMED CORP.

𝗕𝘂𝘆 𝗡𝗼𝘄 𝗔𝗻𝗱 𝗚𝗲𝘁 𝗙𝗹𝗮𝘁 𝗨𝗦𝗗 𝟮𝟬𝟬𝟬 𝗢𝗙𝗙

𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐓𝐡𝐢𝐬 𝐏𝐫𝐞𝐦𝐢𝐮𝐦 𝐑𝐞𝐩𝐨𝐫𝐭 𝐓𝐨 𝐀𝐜𝐜𝐞𝐬𝐬 𝐅𝐮𝐥𝐥 𝐈𝐧𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 @ https://www.coherentmarketinsights.com/promo/buynow/4362

𝐀𝐛𝐨𝐮𝐭 𝐂𝐨𝐡𝐞𝐫𝐞𝐧𝐭 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

Mr. Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.